Pendahuluan
Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari W Anthony Vernon. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.
Rata-rata Profitabilitas Perdagangan
Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.
Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.
Frekuensi Pembaruan: Setiap Hari
Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.
Perusahaan dengan Posisi Orang Dalam yang Dilaporkan
Pengajuan SEC menunjukkan bahwa W Anthony Vernon telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:
Keamanan | Judul | Kepemilikan Terakhir yang Dilaporkan |
---|---|---|
US:NVCR / NovoCure Limited | Director | 179,102 |
US:MKC / McCormick & Company, Incorporated | Director | 11,826 |
US:NUVB / Nuvation Bio Inc. | Director | 118,784 |
US:XENT / Intersect ENT Inc | Director | 9,666 |
US:00BYYT6W4 / Axovant Sciences Ltd. Bond | Director | 70,000 |
US:WWAV / The WhiteWave Foods Co. | Director | 0 |
US:MDVN / Medivation, Inc. | Director | 0 |
US:KRFT / | Director | 199,548 |
US:KFT / | EVP & Pres, Kraft Foods NA | 133,693 |
Cara Membaca Grafik
Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh W Anthony Vernon. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.
Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.
Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.
Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.
Pembelian Orang Dalam NUVB.WS / Panacea Acquisition Corp. - Equity Warrant - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di NUVB.WS / Panacea Acquisition Corp. - Equity Warrant. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Maksimal |
Harga di Maksimal |
Maksimal Keuntungan ($) |
Maksimum Pengembalian (%) |
---|---|---|---|---|---|---|---|
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Penjualan Orang Dalam NUVB.WS / Panacea Acquisition Corp. - Equity Warrant - Analisis Kerugian Jangka Pendek
Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di NUVB.WS / Panacea Acquisition Corp. - Equity Warrant. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Tanggal Perdagangan | Ticker | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
---|---|---|---|---|---|---|---|
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini. |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.
Sejarah Perdagangan Orang Dalam
Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh W Anthony Vernon sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).
Tanggal File | Tanggal Transaksi | Formulir | Ticker | Keamanan | Kode | Saham | Sisa Saham | Persen Ubah |
Bagikan Harga |
Tran Nilai |
Sisa Nilai |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
A - Award | 11,215 | 179,102 | 6.68 | ||||
2025-06-04 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -999 | 167,887 | -0.59 | 17.35 | -17,329 | 2,912,269 | |
2025-03-18 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 1,344 | 11,826 | 12.82 | ||||
2024-06-06 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
A - Award | 4,053 | 169,850 | 2.44 | ||||
2024-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -964 | 164,833 | -0.58 | 23.89 | -23,033 | 3,938,355 | |
2024-03-19 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 1,255 | 10,482 | 13.60 | ||||
2023-06-09 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
A - Award | 3,853 | 165,797 | 2.38 | ||||
2023-03-16 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 1,044 | 9,227 | 12.76 | ||||
2022-05-18 |
|
4 | NUVB |
Nuvation Bio Inc.
Stock Option (Right to Buy) |
A - Award | 118,784 | 118,784 | |||||
2022-04-01 |
|
4 | MKC |
MCCORMICK & CO INC
Options- Right to Buy |
A - Award | 2,711 | 2,711 | |||||
2022-04-01 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 1,044 | 1,044 | |||||
2022-03-17 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
M - Exercise | -1,139 | 0 | -100.00 | ||||
2022-03-17 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 1,139 | 8,183 | 16.17 | ||||
2021-11-02 |
|
4 | NUVB |
Nuvation Bio Inc.
Stock Option (Right to Buy) |
A - Award | 45,229 | 45,229 | |||||
2021-06-11 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 1,499 | 1,499 | |||||
2021-06-11 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
A - Award | 814 | 161,944 | 0.51 | ||||
2021-04-02 |
|
4 | MKC |
MCCORMICK & CO INC
Options - Right to Buy |
A - Award | 3,268 | 3,268 | |||||
2021-04-02 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 1,156 | 1,156 | |||||
2021-03-16 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
M - Exercise | -1,468 | 0 | -100.00 | ||||
2021-03-16 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 1,468 | 7,044 | 26.33 | ||||
2021-02-12 | 3 | NUVB |
Nuvation Bio Inc.
No securities owned. |
0 | ||||||||
2021-02-12 |
|
4 | NUVB |
Nuvation Bio Inc.
Stock Option (Right to Buy) |
A - Award | 187,658 | 187,658 | |||||
2021-02-12 |
|
4 | NUVB |
Nuvation Bio Inc.
Stock Option (Right to Buy) |
A - Award | 51,703 | 51,703 | |||||
2021-02-12 |
|
4 | NUVB |
Nuvation Bio Inc.
Class A Common Stock |
A - Award | 50,000 | 304,100 | 19.68 | 10.00 | 500,000 | 3,041,000 | |
2021-02-12 |
|
4 | NUVB |
Nuvation Bio Inc.
Class A Common Stock |
A - Award | 254,100 | 254,100 | |||||
2020-06-12 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 5,101 | 5,101 | |||||
2020-06-12 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
A - Award | 2,541 | 161,130 | 1.60 | ||||
2020-06-08 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 9,666 | 9,666 | |||||
2020-06-08 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
A - Award | 5,011 | 11,383 | 78.64 | ||||
2020-04-03 |
|
4 | MKC |
MCCORMICK & CO INC
Options - Right to Buy |
A - Award | 2,262 | 2,262 | |||||
2020-04-03 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 734 | 734 | |||||
2020-03-17 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
M - Exercise | -689 | 0 | -100.00 | ||||
2020-03-17 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 689 | 2,788 | 32.83 | ||||
2019-09-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | -100,000 | 158,589 | -38.67 | 91.03 | -9,103,100 | 14,436,515 | |
2019-06-06 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 5,172 | 5,172 | |||||
2019-06-06 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
A - Award | 2,312 | 6,372 | 56.95 | ||||
2019-05-24 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 6,340 | 6,340 | |||||
2019-05-24 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
A - Award | 3,359 | 258,589 | 1.32 | ||||
2019-05-22 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | -6,145 | 0 | -100.00 | ||||
2019-05-22 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 6,145 | 255,230 | 2.47 | 48.87 | 300,306 | 12,473,090 | |
2019-03-29 |
|
4 | MKC |
MCCORMICK & CO INC
Options - Right to Buy |
A - Award | 2,182 | 2,182 | |||||
2019-03-29 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 689 | 689 | |||||
2019-03-19 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
M - Exercise | -962 | 0 | -100.00 | ||||
2019-03-19 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 962 | 2,099 | 84.61 | ||||
2019-01-18 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 3,220 | 3,220 | |||||
2018-06-07 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 3,473 | 3,473 | |||||
2018-06-07 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
A - Award | 1,514 | 4,060 | 59.47 | ||||
2018-06-04 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Unit |
A - Award | 6,145 | 6,145 | |||||
2018-06-04 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 12,345 | 12,345 | |||||
2018-03-30 |
|
4 | MKC |
MCCORMICK & CO INC
Options - Right to Buy |
A - Award | 2,956 | 2,956 | |||||
2018-03-30 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 962 | 962 | |||||
2018-03-19 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
M - Exercise | -990 | 0 | -100.00 | ||||
2018-03-19 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
M - Exercise | 990 | 1,137 | 673.47 | ||||
2017-06-05 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 6,035 | 6,035 | |||||
2017-06-05 |
|
4 | XENT |
Intersect ENT, Inc.
Common Stock |
A - Award | 2,546 | 2,546 | |||||
2017-05-25 |
|
4 | MKC |
MCCORMICK & CO INC
Options - Right to Buy |
A - Award | 3,260 | 3,260 | |||||
2017-05-25 |
|
4 | MKC |
MCCORMICK & CO INC
Restricted Stock Units |
A - Award | 990 | 990 | |||||
2017-05-25 |
|
4 | MKC |
MCCORMICK & CO INC
Common Stock - Voting |
A - Award | 147 | 147 | 102.53 | 15,072 | 15,072 | ||
2017-05-25 | 3 | MKC |
MCCORMICK & CO INC
No securities are benficially owned as of May 23, 2017. |
0 | ||||||||
2017-05-16 |
|
4 | AXON |
Axovant Sciences Ltd.
Stock Option (Right to Buy) |
A - Award | 70,000 | 70,000 | |||||
2017-05-12 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 23,600 | 23,600 | |||||
2017-04-19 |
|
4 | AXON |
Axovant Sciences Ltd.
Common Shares |
P - Purchase | 53,937 | 53,937 | 18.54 | 999,992 | 999,992 | ||
2017-04-13 |
|
4 | WWAV |
WHITEWAVE FOODS Co
stock option (right to buy) |
D - Sale to Issuer | -5,376 | 0 | -100.00 | ||||
2017-04-13 |
|
4 | WWAV |
WHITEWAVE FOODS Co
stock option (right to buy) |
D - Sale to Issuer | -1,226 | 0 | -100.00 | ||||
2017-04-13 |
|
4 | WWAV |
WHITEWAVE FOODS Co
common stock |
D - Sale to Issuer | -6,300 | 0 | -100.00 | 56.25 | -354,375 | ||
2017-04-11 | 3 | AXON |
Axovant Sciences Ltd.
Common Shares |
0 | ||||||||
2017-02-16 |
|
4 | WWAV |
WHITEWAVE FOODS Co
restricted stock unit |
M - Exercise | -1,663 | 0 | -100.00 | ||||
2017-02-16 |
|
4 | WWAV |
WHITEWAVE FOODS Co
common stock |
M - Exercise | 1,663 | 6,300 | 35.86 | ||||
2017-01-23 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Restricted Stock Unit |
M - Exercise | -481 | 0 | -100.00 | ||||
2017-01-23 |
|
4 | WWAV |
WHITEWAVE FOODS Co
common stock |
M - Exercise | 481 | 4,637 | 11.57 | ||||
2017-01-20 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Options (Right to buy) |
A - Award | 7,570 | 7,570 | |||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -6,228 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -6,284 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -9,584 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -12,232 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -30,000 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -60,000 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -60,000 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -60,000 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
U - Other | -15,000 | 0 | -100.00 | ||||
2016-09-30 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
U - Other | -17,742 | 0 | -100.00 | ||||
2016-06-23 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
A - Award | 6,228 | 6,228 | |||||
2016-06-23 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
A - Award | 2,972 | 17,742 | 20.12 | ||||
2016-06-06 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 12,500 | 12,500 | |||||
2016-05-17 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | -249,085 | 0 | -100.00 | ||||
2016-05-17 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 249,085 | 249,085 | 0.17 | 42,344 | 42,344 | ||
2016-05-06 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 21,500 | 21,500 | |||||
2016-02-17 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Non Qualified Stock Option (right to buy) |
A - Award | 5,376 | 1,576 | -141.47 | ||||
2016-02-17 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Restricted Stock Unit |
A - Award | 1,663 | 1,663 | |||||
2016-02-17 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Common stock |
A - Award | 4,156 | 4,156 | |||||
2016-01-05 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Non-Qualified Stock Option (right to buy) |
A - Award | 1,226 | 1,226 | |||||
2016-01-05 |
|
4 | WWAV |
WHITEWAVE FOODS Co
Restricted Stock Unit |
A - Award | 481 | 481 | |||||
2016-01-05 | 3 | WWAV |
WHITEWAVE FOODS Co
No securities owned |
0 | ||||||||
2015-12-16 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
G - Gift | -13,704 | 15,000 | -47.74 | ||||
2015-12-16 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
P - Purchase | 15,000 | 28,704 | 109.46 | 40.69 | 610,350 | 1,167,966 | |
2015-06-18 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
A - Award | 3,142 | 3,142 | |||||
2015-06-18 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
A - Award | 1,578 | 14,217 | 12.49 | ||||
2015-04-10 |
|
4 | XENT |
Intersect ENT, Inc.
Stock Option (right to buy) |
A - Award | 25,000 | 25,000 | |||||
2015-03-09 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 620 | 199,548 | 0.31 | ||||
2015-03-09 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 2,483 | 198,928 | 1.26 | 62.02 | 153,996 | 12,337,515 | |
2015-02-25 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -4,211 | 196,445 | -2.10 | 64.12 | -270,018 | 12,596,446 | |
2015-02-12 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -20,831 | 200,656 | -9.41 | 66.52 | -1,385,616 | 13,347,035 | |
2015-02-12 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 50,172 | 221,487 | 29.29 | ||||
2014-10-03 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -3,888 | 171,315 | -2.22 | 55.88 | -217,242 | 9,572,226 | |
2014-07-01 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
A - Award | 4,792 | 4,792 | |||||
2014-07-01 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
A - Award | 2,250 | 12,639 | 21.66 | ||||
2014-03-10 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 1,630 | 175,203 | 0.94 | ||||
2014-03-10 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 6,522 | 173,573 | 3.90 | 55.65 | 362,949 | 9,659,337 | |
2014-03-03 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Stock Options (right to buy) |
A - Award | 155,818 | 155,818 | |||||
2014-03-03 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 22,259 | 167,051 | 15.37 | ||||
2014-02-26 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -3,443 | 144,792 | -2.32 | 55.32 | -190,450 | 8,009,169 | |
2014-02-13 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -19,472 | 148,235 | -11.61 | 53.15 | -1,034,976 | 7,878,987 | |
2014-02-13 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 47,123 | 167,707 | 39.08 | ||||
2013-07-02 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
A - Award | 6,116 | 6,116 | |||||
2013-07-02 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
A - Award | 3,557 | 10,389 | 52.06 | ||||
2013-03-19 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
M - Exercise | -30,000 | 0 | -100.00 | ||||
2013-03-19 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
M - Exercise | -30,000 | 0 | -100.00 | ||||
2013-03-19 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -60,000 | 6,832 | -89.78 | 45.91 | -2,754,600 | 313,657 | |
2013-03-19 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
M - Exercise | 30,000 | 66,832 | 81.45 | 6.96 | 208,950 | 465,485 | |
2013-03-19 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
M - Exercise | 30,000 | 36,832 | 439.11 | 9.38 | 281,250 | 345,300 | |
2013-02-26 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Stock Options (right to buy) |
A - Award | 172,990 | 172,990 | |||||
2013-02-26 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 24,720 | 120,584 | 25.79 | ||||
2013-02-26 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -3,492 | 95,864 | -3.51 | 47.20 | -164,805 | 4,524,301 | |
2013-02-07 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
F - Taxes | -28,170 | 99,356 | -22.09 | 47.16 | -1,328,497 | 4,685,629 | |
2013-02-07 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 66,404 | 127,526 | 108.64 | ||||
2012-10-04 |
|
4 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
A - Award | 16,560 | 61,122 | 37.16 | ||||
2012-08-21 |
|
4 | KFT |
KRAFT FOODS INC
Class A Common Stock |
F - Taxes | -4,962 | 133,693 | -3.58 | 40.53 | -201,110 | 5,418,577 | |
2012-08-17 | 3 | KRFT |
Kraft Foods Group, Inc.
Common Stock |
0 | ||||||||
2012-07-17 |
|
4 | MDVN |
MEDIVATION, INC.
Director Stock Option (right to buy) |
A - Award | 7,500 | 7,500 | |||||
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
M - Exercise | -31,094 | 0 | -100.00 | ||||
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -4,900 | 3,416 | -58.92 | 83.21 | -407,729 | 284,245 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -26,194 | 8,316 | -75.90 | 82.32 | -2,156,290 | 684,573 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
M - Exercise | 31,094 | 34,510 | 910.25 | 4.45 | 138,368 | 153,570 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
M - Exercise | -43,206 | 31,094 | -58.15 | ||||
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -6,040 | 3,416 | -63.87 | 83.14 | -502,166 | 284,006 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -37,166 | 9,456 | -79.72 | 82.44 | -3,063,965 | 779,553 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
M - Exercise | 43,206 | 46,622 | 1,264.81 | 4.45 | 192,267 | 207,468 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Stock Option (Right to Buy) |
M - Exercise | -27,600 | 74,300 | -27.09 | ||||
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -400 | 3,416 | -10.48 | 86.50 | -34,600 | 295,484 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -9,601 | 3,816 | -71.56 | 85.23 | -818,293 | 325,238 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
S - Sale | -17,599 | 13,417 | -56.74 | 84.40 | -1,485,356 | 1,132,395 | |
2012-06-15 |
|
4 | MDVN |
MEDIVATION, INC.
Common Stock |
M - Exercise | 27,600 | 31,016 | 807.96 | 4.45 | 122,820 | 138,021 | |
2012-02-27 |
|
4 | KFT |
KRAFT FOODS INC
Stock Options (right to buy) |
A - Award | 165,800 | 165,800 | |||||
2012-02-27 |
|
4 | KFT |
KRAFT FOODS INC
Class A Common Stock |
A - Award | 27,640 | 138,655 | 24.90 | ||||
2012-02-27 |
|
4 | KFT |
KRAFT FOODS INC
Class A Common Stock |
F - Taxes | -20,954 | 111,015 | -15.88 | 38.00 | -796,147 | 4,218,015 | |
2012-02-27 |
|
4 | KFT |
KRAFT FOODS INC
Class A Common Stock |
A - Award | 56,795 | 131,969 | 75.55 | ||||
2011-02-25 |
|
4 | KFT |
KRAFT FOODS INC
Stock Options (right to buy) |
A - Award | 131,980 | 131,980 | |||||
2011-02-25 |
|
4 | KFT |
KRAFT FOODS INC
Class A Common Stock |
A - Award | 22,000 | 78,939 | 38.64 | ||||
2009-08-18 | 3 | KFT |
KRAFT FOODS INC
Class A Common Stock |
2,245 |